MPR Weekly Dose #61 - Sitagliptin findings in pediatrics; Obesity treatment gains expanded approval; The FDA issue a CRL; And a new transdermal contraceptive

<p><span style="font-weight: 400;">This week we cover new findings for the diabetes drug sitagliptin in pediatrics; An obesity treatment has approval expanded; The FDA issue a Complete Response Letter for an outpatient alternative treatment; And news of availability for a transdermal contraceptive patch.</span></p>